Genta, Inc. (GNTA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA)

GNTA 2.300

+0.4%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ptlusa who wrote (1866)	4/23/2007 5:56:36 PM
From: Art Bechhoefer	of 1870

Yes, the new melanoma testing is good news, but what I don't understand is why the earlier results were thought to be insufficient in terms of efficacy. So if the new testing gives as good results as that so far, it's likely that at least some regulatory agencies will grant approval. The first application went before European regulators. Now it looks like the newer tests may be submitted in a number of other countries, including Australia. The bad news is that the longer it takes to get approval, the worse off the company is financially, and the more likely the stock will be diluted prior to earning anything. Art

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next